ELDN icon

Eledon Pharmaceuticals
ELDN

Overview Fund Activity

31 hedge funds and large institutions have $15.9M invested in Eledon Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
-1
Holders Change %
-3.13%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
11
Closed
3
Calls
$57K
Puts
–
Net Calls
+$57K
Net Calls Change
+$126K

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
$79K
2
UBS Group
UBS Group
Switzerland
$11K
3
Geode Capital Management
Geode Capital Management
Massachusetts
$314K
4
Morgan Stanley
Morgan Stanley
New York
$5K

Top Sellers

1
WP
Woodline Partners
California
$1.26M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
$1.05M
3
EP
Eversept Partners
New York
$144K
4
V
Veritable
Delaware
$0
5
Two Sigma Advisers
Two Sigma Advisers
New York
$110K
Name Holding Trade Value Shares
Change 		Shares
Change %
SWM
26
Spire Wealth Management
Virginia
$1K -$700 -350 -41%
Federated Hermes
27
Federated Hermes
Pennsylvania
$1K -$485 -197 -33%
IA
28
IFP Advisors
Florida
$1K – – –
V
29
Veritable
Delaware
– -$130K -33,092 Closed
Envestnet Asset Management
30
Envestnet Asset Management
Illinois
– -$66K -16,726 Closed
Millennium Management
31
Millennium Management
New York
– -$47K -11,951 Closed
1
2